US SEC Filings Daily Market Digest — September 08, 2026

08-09-2026

Ocean Power Technologies, Inc. (OPTT) filed an S-1 registration statement with the SEC on September 8, 2026, for a best-efforts offering of common stock and common warrants. The company has 270,138,823 shares outstanding as of September 1, 2026, and the offering has no minimum amount required, meaning proceeds could be substantially less than the maximum. The filing highlights significant risks, including a history of operating losses, volatile stock price, immediate dilution for investors, and the speculative nature of the warrants, with no established trading market for them.

• · The offering is a 'best efforts' offering with no minimum amount required, so proceeds may be substantially less than the maximum.
• · The company has a history of operating losses and expects to continue incurring losses for at least the short term.
• · Investors will experience immediate and substantial dilution in net tangible book value per share.
• · The warrants offered have no established trading market and do not confer voting rights or dividend rights.
• · The exercise price of the warrants will not be adjusted for dilutive issuances of securities.

08-09-2026

WaFd, Inc. (WAFD) filed a DEFA14A proxy statement regarding its proposed merger with EverBank Financial Corp. The transaction is expected to close in early 2027, combining two regional banks to create a network of over 250 branches and a nationwide digital banking platform. The filing urges shareholders to read the definitive proxy statement when available and notes that the merger is subject to regulatory and shareholder approvals, with no financial metrics or performance data provided.

• · The transaction is expected to close in early 2027.
• · Both banks will operate separately until closing.
• · No changes to FDIC coverage or customer accounts until closing.
• · Shareholders are urged to read the definitive proxy statement when filed with the SEC.
• · Free copies of the proxy statement can be obtained from the SEC website or by contacting Brad Goode at (206) 626-8178.

08-09-2026

AIR Global PLC published an investor presentation on September 8, 2026, as furnished via SEC Form 6-K. The filing does not provide any financial data or performance metrics, only referencing the presentation's availability. No positive or negative performance details are disclosed in the filing itself.

08-09-2026

Galmed Pharmaceuticals Ltd. (GLMD) announced on September 3, 2026 that it regained compliance with Nasdaq's minimum bid price requirement (Rule 5550(a)(2)). The company had previously failed to maintain a $1.00 minimum bid price and received two compliance periods, ultimately meeting the requirement by achieving a closing bid price of at least $1.00 for 10 consecutive trading days from August 20 to September 2, 2026. The matter is now closed, and the company's shares will continue to be listed on Nasdaq.

• · The company was initially notified of non-compliance on January 29, 2026.
• · The initial compliance period ended July 28, 2026, and the company received an additional 180-day compliance period.
• · The compliance period ran from August 20, 2026 through September 2, 2026.
• · The company is now in compliance with all applicable listing standards.

08-09-2026

Cosan S.A. has filed a Form 25 with the SEC to voluntarily withdraw its American Depositary Shares (ADSs), each representing four common shares, from listing and registration on the New York Stock Exchange (NYSE). The delisting is effective as of September 8, 2026, and the company certifies it has met all requirements for the voluntary withdrawal. This move will terminate the company's SEC reporting obligations under Section 12(b) of the Exchange Act.

• · The delisting is voluntary under SEC Rule 17 CFR 240.12d2-2(c).
• · Each ADS represents four common shares of Cosan S.A.
• · The company's principal executive offices are in São Paulo, Brazil.
• · The filing date is September 8, 2026.

08-09-2026

KE Holdings Inc. filed a Form 6-K with the SEC for September 2026, attaching multiple Next Day Disclosure Returns and a Monthly Return on movements in securities. The filings cover dates from August 31 to September 4, 2026, and are routine disclosures of share transactions and securities movements. No financial results or material business developments were reported.

• · Filing includes Next Day Disclosure Returns dated August 31, September 1, 2, 3, and 4, 2026.
• · Also includes a Monthly Return for Equity Issuer on Movements in Securities.
• · No financial data or operational updates were provided in the filing.

08-09-2026

Pampa Energia S.A. filed a Form 6-K on September 8, 2026, announcing that its Fertilizer Project received approval under Argentina's RIGI regime. The project is expected to benefit from the RIGI regime's incentives, but the release provides no financial details or timelines. No financial or operational metrics were disclosed, so no period-over-period comparisons are possible.

08-09-2026

Belite Bio, Inc. announced the submission of a New Drug Application (NDA) to Japan's Ministry of Health, Labour, and Welfare under the Sakigake Designation System for Tinlarebant, a treatment for Stargardt Disease Type 1. This regulatory milestone could accelerate approval in Japan, but the filing does not disclose financial figures, prior-period comparisons, or any negative or flat metrics.

• · The NDA submission is for Stargardt Disease Type 1, a rare genetic eye disease.
• · The Sakigake Designation System is a Japanese regulatory pathway designed to expedite review of innovative therapies.
• · The filing is a Form 6-K submitted to the SEC on September 8, 2026.

08-09-2026

ICICI Bank disclosed that the Reserve Bank of India (RBI) has approved Life Insurance Corporation of India (LIC) to acquire an aggregate holding of up to 9.99% of the paid-up share capital or voting rights in the Bank within one year from September 4, 2026. The approval is subject to certain conditions, including compliance with statutory and regulatory provisions. This regulatory approval could lead to a significant increase in LIC's stake in ICICI Bank, but the filing does not provide any financial performance data or period-over-period comparisons.

• · RBI approval letter dated September 4, 2026
• · Approval valid for one year from date of RBI letter; otherwise stands cancelled
• · Approval is subject to conditions including compliance with relevant statutory and regulatory provisions

08-09-2026

Greenland Energy Company (GLND) announced a proposed all-share acquisition of 80 Mile plc, a UK-based company, via a Rule 2.4 Announcement published in London. The transaction is structured as a merger through an all-share acquisition, indicating no cash consideration. The filing is a Regulation FD disclosure and does not provide financial terms, deal value, or expected synergies.

• · The acquisition is structured as an all-share deal, meaning Greenland Energy will issue shares to 80 Mile plc shareholders.
• · The announcement was made under Rule 2.4 of the UK City Code on Takeovers and Mergers, which typically requires a firm intention to make an offer or a statement that no offer will be made.
• · No financial details, valuation, or expected closing timeline were disclosed in this filing.

08-09-2026

BW LPG Ltd announced that its shares will trade ex-dividend on the Oslo Stock Exchange from September 7, 2026, and on the New York Stock Exchange from September 8, 2026. The cash dividend for Q2 2026 is NOK 8.8914 per share for NOK-denominated shareholders and US$0.95 per share for USD-denominated shareholders. This is a routine corporate action with no negative or flat performance metrics to report.

• · The dividend is for Q2 2026.
• · BW LPG is the world's leading owner and operator of LPG vessels.
• · BW Group controls a fleet of over 400 vessels transporting oil, gas and dry commodities.

08-09-2026

AITX issued a press release on September 8, 2026, reporting preliminary, unaudited cash payment data for July and August 2026, indicating that its company-wide cost reduction plan is progressing faster than expected. The company aims to reduce monthly cash SG&A by approximately $200,000 by December 31, 2026, and achieve positive monthly cash flow from operations by calendar year-end. However, the company has never been profitable, has a going concern qualification, and faces significant risks including reliance on dilutive external financing.

• · The July and August 2026 figures are preliminary, unaudited, and unreviewed, and are not GAAP measures.
• · The Plan's baseline is the fiscal quarter ended May 31, 2026, and the monthly comparison is separate from that baseline.
• · The company has not been profitable in any fiscal year of its operating history.
• · Auditors issued a going concern qualification expressing substantial doubt about the company's ability to continue as a going concern.
• · Cash on hand is not sufficient to fund operations for any extended period without additional financing, which is expected to be dilutive.
• · The company does not qualify for the safe harbor for forward-looking statements under the Private Securities Litigation Reform Act of 1995.

08-09-2026

Holtec Nuclear Corp filed an S-1/A registration statement for its IPO. For the six months ended June 30, 2026, total revenue was $269.9M, down 5.8% from $286.6M in the prior-year period, while net income was $205.6M compared to a net loss in the prior period. However, the Palisades segment generated no revenue and posted a $39.8M operating loss, and the company's total inventories declined 23.1% to $20.5M.

• · The company had no recorded allowance for credit losses on accounts receivable as of June 30, 2026 or December 31, 2025.
• · The company expects the DOE to begin accepting spent nuclear fuel in 2041.
• · The long-term DOE receivable for spent fuel was $648.8M as of June 30, 2026, net of a $437.0M allowance for cost adjustments.
• · Depreciation expense increased 294.7% YoY to $45.0M for the six months ended June 30, 2026.
• · The Palisades segment had no revenue in either period and an operating loss of $39.8M for the six months ended June 30, 2026.
• · The company recorded a $202.2M realized gain on investments and a $44.0M unrealized loss on investments for the six months ended June 30, 2026.
• · The company's asset retirement obligation decreased 9.6% to $1.6B as of June 30, 2026, while the associated NDT fund was $2.8B.
• · Accrued expenses and other current liabilities decreased 21.4% to $205.7M as of June 30, 2026, driven by a decline in vendor accruals.
• · The company's total inventories declined 23.1% to $20.5M as of June 30, 2026, with raw materials and finished goods both decreasing.

08-09-2026

Greenwave Technology Solutions, Inc. filed an 8-K on September 8, 2026, announcing the creation of 3,750 shares of Series B Convertible Preferred Stock, authorized by the Board on September 4, 2026. The preferred shares are convertible into common stock at an initial conversion price of $5.24 per share, subject to adjustment, and rank senior to common stock but junior to any future Senior Preferred Stock. The filing also references a Preferred Stock Purchase Agreement dated September 7, 2026, indicating a concurrent capital raise, though no specific proceeds or use of funds are disclosed.

• · The Series B Preferred Stock ranks senior to common stock (Junior Stock) and on parity with any Parity Stock, but junior to any Senior Preferred Stock.
• · Conversion price is subject to adjustment and will be reduced to the lowest of the 5-day VWAP prior to the Effective Date or the then-current conversion price.
• · The filing includes detailed conversion mechanics, including a 1-Trading Day share delivery deadline and buy-in provisions if the company fails to deliver shares on time.
• · No dividends are mandatory; dividends are payable only when declared by the Board in its sole discretion.
• · The Preferred Stock Purchase Agreement dated September 7, 2026, is referenced but not filed as an exhibit, so specific terms of the capital raise (e.g., amount raised, investors) are not disclosed.

08-09-2026

Equinor ASA disclosed transactions under the third tranche of its 2026 share buy-back programme, repurchasing 700,000 shares on the Oslo Stock Exchange (OSE) between August 31 and September 4, 2026, for a total of approximately NOK 280.7 million. The daily weighted average share price ranged from NOK 396.22 to NOK 405.83. Accumulated buy-backs under the tranche total 4,348,520 shares at an average price of NOK 388.03, for a total value of about NOK 1.687 billion.

• · Daily weighted average share price ranged from NOK 396.22 to NOK 405.83 during the period.
• · All repurchases were executed on the Oslo Stock Exchange (OSE); no trades on CEUX or TQEX.
• · Previously disclosed buy-backs under the tranche totaled 3,648,520 shares at an average price of NOK 385.55.

08-09-2026

Novartis AG disclosed a reference to a publication in Molecular Therapy regarding the phase 1/2 MARINA study of delpacibart etedesiran for myotonic dystrophy type 1. The study reportedly shows improvement in the molecular pathology of the disease, but no financial, operational results, or updates on regulatory or commercial progress are provided in this brief filing.

• · Publication reference: Molecular Therapy, 2026;34(5). doi:10.1016/j.ymthe.2026.03.013.
• · Study is Phase 1/2, focused on myotonic dystrophy type 1.

08-09-2026

ING Groep N.V. filed a Form 6-K with the SEC on September 8, 2026, attaching a press release of the same date. The filing is a routine foreign issuer report under Rule 13a-16 or 15d-16, with no financial data or material events disclosed in the cover filing itself.

• · Filing is a Form 6-K for the month of September 2026.
• · Commission File Number: 001-14642.
• · The press release (Exhibit 99.1) is incorporated by reference but not included in the provided text.

08-09-2026

Nayax Ltd. disclosed the resignation of director Eran Havshush effective September 1, 2026, following the adoption of a revised Remuneration Policy that prohibits non-executive directors from providing services beyond their director role. Mr. Havshush will continue as a service provider under a services agreement, and his resignation was not due to any disagreement with company policies. The change is a governance adjustment with no direct financial impact.

• · Mr. Havshush had served on the Board since July 2024.
• · The revised Remuneration Policy was adopted at a general meeting of shareholders in May 2026.
• · The prohibition on non-executive directors providing other services became effective September 1, 2026.
• · The Form 6-K is incorporated by reference into multiple SEC and ISA registration statements (File Nos. 333-296388, 333-267542, 333-274812).

08-09-2026

Baidu, Inc. announced the inclusion of its Class A ordinary shares in the Shenzhen-Hong Kong Stock Connect and Shanghai-Hong Kong Stock Connect programs, effective September 8, 2026. This inclusion is expected to broaden the company's investor base and improve liquidity by allowing mainland Chinese investors to trade its shares. No financial figures were disclosed in this filing.

• · Inclusion effective September 8, 2026
• · Class A ordinary shares are now eligible for trading via both Stock Connect programs
• · Filing is a Form 6-K under SEC Rule 13a-16 or 15d-16

08-09-2026

Circle Internet Group (CRCL) announced a definitive agreement to acquire Tazapay, a Singapore-based B2B cross-border payments infrastructure company, expected to close in 2027 subject to regulatory approvals including from the Monetary Authority of Singapore. The acquisition brings over $25 billion in annualized payment volume, 60+ banking and fintech partners, and payout rails in 100+ markets, with approximately 60% of Tazapay's transaction volume already involving stablecoins. While the deal is strategically positive, it carries execution and regulatory risks, and no financial terms were disclosed.

• · Tazapay has been a design partner for Circle Payments Network since 2025.
• · Tazapay stablecoin services are provided by Tazapay Canada Corp., a registered Money Services Business under FINTRAC-CANAFE (Registration number M21439799).
• · Tazapay customers can expect no disruption to service, APIs, pricing, or support.
• · The acquisition is subject to customary closing conditions and regulatory approvals, including from the Monetary Authority of Singapore.
• · No financial terms of the acquisition were disclosed.

08-09-2026

Alterity Therapeutics Limited, a development-stage biotech, filed a Form 6-K with the SEC for September 2026, primarily to submit a cleansing notice under Section 708A of the Australian Corporations Act. The filing contains no financial results or operational updates, only a routine corporate disclosure related to share issuance. No material financial or operational information was provided.

• · The Form 6-K is incorporated by reference into multiple registration statements (Form S-8 and Form F-3).
• · The filing includes a cleansing notice under Section 708A, which is a routine disclosure under Australian securities law.

08-09-2026

Newlinks Technology Ltd and its affiliates disclosed beneficial ownership of 40,754,920,572 Class A ordinary shares (51.9% of total ordinary shares) and 53.6% voting power (excluding Class D shares) in NaaS Technology Inc. as of August 31, 2026. Including 16,000,000 non-convertible Class D shares held through Envision, Newlinks' total voting power rises to 57.7%. The filing details a multi-class share structure with Class B (10 votes), Class C (2 votes), and Class D (500 votes) shares, and notes that voting control of Class B shares is held by Zhen Dai, while Class C voting is allocated proportionally among other Newlinks shareholders.

• · The filing is an amendment (SC 13D/A) filed on September 8, 2026, with an event date of August 31, 2026.
• · Newlinks' beneficial ownership includes shares held directly and through wholly-owned subsidiaries Envision, Linkage (84.31% owned), and Digital.
• · Class B and Class C shares are convertible into Class A shares at any time; Class D shares are non-convertible.
• · Class A shares carry 1 vote, Class B 10 votes, Class C 2 votes, and Class D 500 votes per share.
• · Voting power of Class B shares is controlled by Zhen Dai; Class C voting power is allocated proportionally among Newlinks shareholders other than Zhen Dai.
• · The filing excludes certain shares from the total outstanding count: ADSs reserved for future issuances, convertible notes to LMR, shares under a Share Subscription Facility Agreement, and warrants to LMR.
• · Principal beneficial owners of Newlinks (over 5%) include Zhen Dai, entities affiliated with Joy Capital, and BCPE Nutcracker Cayman, L.P.

08-09-2026

Brightstar Lottery PLC announced a tender offer for any and all of its outstanding €500,000,000 2.375% Senior Secured Notes due 2028 and a benchmark offering of new euro-denominated senior secured notes due 2032. The company intends to use the proceeds to fund the tender offer, repay revolving credit facility borrowings, and pay fees, with the goal of extending the weighted average maturity of its debt. The offering is a condition to the tender offer, though the company may waive that condition.

• · The New Notes will be guaranteed on a senior basis by certain of the company's wholly owned subsidiaries.
• · Application has been made for the New Notes to be listed on the Official List of Euronext Dublin and admitted to trading on the Global Exchange Market of Euronext Dublin.
• · The tender offer is for Regulation S interests in the existing notes.
• · The closing of the Offering is a condition to the Offer, although the Company may waive that condition in whole or in part.

08-09-2026

Megan Holdings Ltd. announced a 1-for-30 share consolidation to become effective on Nasdaq on September 17, 2026, replacing its earlier 1-for-40 plan. The reverse split is intended to meet Nasdaq listing requirements, but no financial data is provided to assess underlying performance.

• · The share consolidation ratio was changed from 1-for-40 to 1-for-30.
• · The marketplace effective date was moved from September 8, 2026 to September 17, 2026.
• · Fractional shares will be rounded up to the nearest whole share at the participant level.
• · Trading symbol 'MGN' remains unchanged.

08-09-2026

Lantheus Holdings, Inc. has filed a definitive proxy statement (DEFM14A) for a special meeting of stockholders to vote on a proposed merger agreement under which the company will be acquired by Parent and become a wholly owned subsidiary, with its common stock delisted from Nasdaq. The merger is expected to close in the first half of 2027, subject to stockholder approval and regulatory clearances. Termination fees are asymmetric: Lantheus would pay Parent $228 million under certain circumstances, while Parent would pay Lantheus $385 million or a regulatory termination fee of $100 million under other conditions.

• · Lantheus is a radiopharmaceutical-focused company headquartered in Bedford, Massachusetts with offices in New Jersey, Canada, Germany, Switzerland, Sweden and the United Kingdom.
• · The company's commercial products are used by cardiologists, internists, neurologists, nuclear medicine physicians, oncologists, radiologists, sonographers, technologists, and urologists.
• · PYLARIFY TruVu, a new formulation of F-18 prostate-specific membrane antigen PET imaging agent, was approved by the FDA on March 6, 2026.
• · LNTH-2501, an investigational kit for Gallium-68 edotreotide injection, received a Complete Response Letter from the FDA on June 26, 2026, with unresolved facility inspection related conditions.
• · PNT2003 received FDA tentative approval earlier in 2026, but faces patent litigation on appeal before the Court of Appeals for the Federal Circuit.
• · The company has experienced recent turnover in its leadership and senior management team.
• · Stockholder litigation in connection with the proposed acquisition may result in significant costs of defense, indemnification and liability.

08-09-2026

Instinct Bio Technical Company Holdings Inc. (BIOT) filed a Form 6-K on September 8, 2026, reporting a press release issued on September 4, 2026, regarding an operational update on its GENRÊVER CLINIC platform in Indonesia and product development initiatives with Invitrx Therapeutics, Inc. and PT Parva Candela. The filing does not contain any financial results or quantitative performance data.

• · The press release was issued on September 4, 2026.
• · The filing is a Form 6-K for the month of September 2026.
• · The company's principal executive offices are located in Tokyo, Japan.
• · The company files annual reports under Form 20-F.

08-09-2026

Bilibili Inc. announced the pricing of US$700 million in convertible senior notes, a concurrent equity placement, and share repurchases. The company is raising debt capital while also buying back shares, indicating a capital structure optimization strategy.

• · The convertible senior notes are priced at US$700 million aggregate principal amount.
• · The offering includes a concurrent equity placement and share repurchases.
• · The filing was made with the SEC on September 8, 2026, as a Form 6-K.

08-09-2026

Ecopetrol S.A. filed a Form 6-K with the SEC for the month of September 2026, signed by CFO Alfonso Camilo Barco. The filing is a routine foreign issuer report and does not contain any financial results, material events, or operational updates. No quantitative data, named entities beyond the signatory, or key data points are provided in the filing.

08-09-2026

Zhihu Inc. filed a Form 6-K with the SEC for September 2026, attaching a monthly return on movements in securities for its equity issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules. The report is a routine administrative filing by the CFO and does not contain financial results or operational data.

08-09-2026

This is a routine SEC Form 6-K filing by Grupo Televisa, S.A.B. for the period ending September 8, 2026. The filing contains no substantive financial or operational updates, only the signature of the Legal Vice President and General Counsel. No material information is disclosed.

08-09-2026

HDFC Bank Limited filed a Form 6-K with the SEC for the month of September 2026, as a routine foreign issuer report. The filing includes a disclosure exhibit (Exhibit 99) but no specific financial results or material events are detailed in the cover page. The report is signed by Company Secretary Ajay Agarwal.

• · Filing is a Form 6-K for the month of September 2026.
• · Commission File Number: 001-15216.
• · Exhibit 99 is described as 'Disclosure' but its content is not specified in the provided text.

08-09-2026

YPF SOCIEDAD ANONIMA filed a 6-K report on September 8, 2026, detailing a tender offer for two series of its outstanding senior notes. The company is offering to purchase up to $643,428,000 of its 6.950% Senior Notes due 2027 at a consideration of $1,017.50 per $1,000 principal, and up to $640,999,934 of its 2.500%/9.000% Step Up Amortizing Notes due 2029 at $1,042.00 per $1,000 principal, with acceptance priority levels of 1 and 2 respectively.

• · The tender offer has two acceptance priority levels: Priority 1 for the 2027 notes and Priority 2 for the 2029 notes.
• · CUSIP and ISIN numbers are provided for both series of notes.

08-09-2026

Gilat Satellite Networks completed a $100 million private placement of convertible notes on September 7, 2026. The notes carry a 3.75% annual interest rate, mature in 2031, and are convertible at $16.00 per share. Proceeds will fund general corporate purposes, with a focus on next-generation satellite and space technologies. The offering was made only in Israel under Regulation S, and the notes are unregistered.

• · The notes mature on September 1, 2031.
• · Initial conversion price is $16.00 per Ordinary Share.
• · If the share price does not average at least $15.00 for 30 consecutive days ending 18 months after issuance, the interest rate increases by 1.25%.
• · Gilat may force conversion if the share price exceeds $20.00 for 10 consecutive trading days, subject to conditions.
• · The offering was made only in Israel and not to U.S. persons, under Regulation S.
• · Gilat must file a resale registration statement within 12 months of closing.

08-09-2026

Brookfield Asset Management Ltd. filed an 8-K on September 8, 2026, to announce the issuance of a press release (Exhibit 99.1) regarding an unspecified other event. The filing does not disclose any financial results, material agreements, or regulatory actions, and the press release content is not included in the filing.

• · The 8-K was filed under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits).
• · The press release is dated September 8, 2026, but its content is not summarized in the filing.
• · The registrant is incorporated in British Columbia, Canada, with principal executive offices in New York, NY.
• · Class A Limited Voting Shares trade on the NYSE under the symbol BAM.

08-09-2026

Indaptus Therapeutics entered into an Amended and Restated At the Market Offering Agreement with H.C. Wainwright & Co., LLC on August 28, 2026, replacing the prior 2022 agreement. The new ATM program allows the company to sell up to $100,000,000 of common stock at market prices, with Wainwright receiving a 3.0% placement fee. The filing is an amendment to correct the original 8-K and includes updated dilution disclosure; no sales are guaranteed under the agreement.

• · The Sales Agreement amends and restates the prior At The Market Offering Agreement dated June 1, 2022.
• · Shares sold under the prior agreement do not count toward the $100,000,000 limit.
• · The company filed a prospectus supplement dated August 31, 2026, amended September 4, 2026, as part of the shelf registration statement on Form S-3 (File No. 333-289573) declared effective August 20, 2025.
• · Wainwright may sell shares via any method permitted under Rule 415, including direct market sales, through market makers, or in privately negotiated transactions with prior written approval.
• · The company may also sell shares to Wainwright as principal under a separate terms agreement.
• · The company has no obligation to sell any shares, and either party may suspend the offering at any time.
• · The company agreed to indemnify Wainwright and reimburse certain legal fees and expenses.
• · The amendment (8-K/A) was filed solely to update the dilution section of the prospectus supplement; no other changes were made to the original 8-K.

08-09-2026

AMC Global Media Inc. (AMCX) disclosed a settlement agreement resolving a breach of contract lawsuit with Robert Kirkman and other plaintiffs related to The Walking Dead and Fear The Walking Dead. The total settlement consideration is $120 million, comprising an $85 million cash payment due by September 18, 2026, and a $35 million advance against future participation amounts due by January 31, 2027. As a result, the company reduced its full-year 2026 free cash flow guidance from approximately $220 million to approximately $150 million, though adjusted operating income and revenue outlook remain unchanged.

• · The lawsuit was initially filed in 2022 and trial was scheduled to begin October 27, 2026.
• · The $85 million cash payment is due by September 18, 2026.
• · The $35 million portion will be treated as an advance against Modified Adjusted Gross Receipts participation amounts for The Walking Dead and Fear The Walking Dead.
• · The company is taking a charge of approximately $85 million in the quarter ending September 30, 2026.
• · Excluding the one-time items, free cash flow guidance for 2026 remains unchanged.
• · Adjusted operating income will not be impacted by the settlement.
• · Revenue and adjusted operating income outlook remain unchanged.

08-09-2026

Hawaiian Electric Industries, Inc. (HEI) filed an 8-K on September 8, 2026, furnishing a presentation for investor meetings beginning on or after that date. The filing is a routine Regulation FD disclosure and does not contain any financial results, operational updates, or material events. No specific quantitative data or performance metrics were provided in the filing.

• · The investor presentation is attached as Exhibit 99 and posted on the company's website at www.hei.com.
• · The filing is not deemed 'filed' under the Exchange Act and is not incorporated by reference into other filings.

08-09-2026

Zoomcar Holdings, Inc. completed the Fifth Closing of its private placement of Series A Units on August 31 and September 4, 2026, issuing 80 Units for aggregate consideration of approximately $80,000. The offering was primarily non-cash, with 60 Units issued to settle $60,000 in accrued obligations and only 20 Units for cash, generating $20,000 in proceeds. The scheduled termination date was extended from September 4 to September 20, 2026, and the offering remains open for up to $5 million in Units (plus an overallotment option).

• · The Preferred Shares have a stated value of $1,000 per share and an initial conversion price of $0.05 per share of Common Stock.
• · Warrants have an exercise price of $0.0625 per share and expire five years from issuance.
• · The offering is conducted under Section 4(a)(2) and Rule 506(c) of Regulation D.
• · The Company extended the offering termination date from September 4 to September 20, 2026.
• · The Registration Rights Agreement requires filing a resale registration statement within 15 calendar days of the Fifth Closing.
• · The number of shares issuable upon conversion/exercise does not reflect the reverse stock split approved on August 11, 2026.

08-09-2026

Synergy CHC Corp. (SNYR) filed for Chapter 11 bankruptcy on September 4, 2026, in the U.S. Bankruptcy Court for the District of Columbia (Case No. 26-465-ELG). The company intends to file a plan of liquidation or reorganization within 120 days. In connection with the filing, four directors (Alfred Baumeler, Nitin Kaushal, J. Paul SoRelle, Teresa Thompson) resigned, and Alfred Baumeler also resigned as President; Jack Ross remains the sole director. Lauren P. Berret of Eisner Advisory Group LLC was engaged as chief restructuring officer effective August 26, 2026.

• · The bankruptcy case is captioned In re Synergy CHC Corp., Case No. 26-465-ELG, in the United States Bankruptcy Court for the District of Columbia.
• · The company has engaged The VerStandig Law Firm, LLC as counsel and advisor in connection with the bankruptcy case.
• · The resignations of the four directors were not the result of any disagreement with the company regarding operations, policies, or practices.
• · Alfred Baumeler's resignation as President was effective August 31, 2026.
• · The company's common stock trades on Nasdaq under the symbol SNYR.

08-09-2026

RBB Bancorp announced that EVP and COO Gary Fan will depart effective September 30, 2026, after a mutual decision not to renew his employment agreement beyond December 4, 2026, as part of a leadership transition plan. He will receive a severance payment of six months' base salary, contingent on signing a release. The filing is a routine officer departure with no financial results or regulatory action.

• · Gary Fan's employment agreement was set to expire December 4, 2026.
• · Severance is six months of current annual base salary, conditioned on a general release of claims.
• · The departure is effective September 30, 2026, before the contract expiration.

08-09-2026

Vivos Therapeutics entered into twelve exchange agreements with Streeterville Capital on August 31, 2026, partitioning $2.86M of its outstanding secured promissory note into separate notes to be exchanged for up to 11.45M common shares at an average price of $0.25 per share. The exchanges reduce the Streeterville Note balance to $3.7M but will increase the company's outstanding share count from 22.16M to 33.61M (a 52% dilution relative to pre-exchange shares), subject to a 4.9% beneficial ownership limitation and sell-down condition. No cash proceeds were received by the company, and the exchanges are structured to avoid registration under Section 3(a)(9) of the Securities Act.

• · The Exchange Shares will be issued without restrictive legend under Section 3(a)(9) of the Securities Act, and the holding period for Rule 144 tacks to the original note issue date of June 9, 2025.
• · The 4.9% beneficial ownership limitation and sell-down condition cannot be increased, waived, or amended without stockholder approval per Nasdaq Listing Rule 5635(b).
• · No commission or other remuneration was paid for soliciting the exchanges.
• · The Partitioned Notes have principal amounts ranging from $232,325.25 to $244,553.00, each exchangeable for 929,301 to 978,212 shares.

08-09-2026

Laird Superfood, Inc. appointed Mark Johnson as Chief Financial Officer, effective October 1, 2026. Johnson, a seasoned CPG finance executive with 25+ years of experience, joins from Tropicana Brands Group and will report to CEO Jason Vieth.

• · Mark Johnson holds an M.B.A. in finance from the Carlson School of Management, University of Minnesota, and a B.A. in Economics from the University of Wisconsin Madison.
• · He will serve as both principal financial officer and principal accounting officer.
• · Laird Superfood co-founded in 2015 by big-wave surfer Laird Hamilton.

08-09-2026

CFO & SVP Liu Chitung acquired 1,000,000 Common Shares. Liu Chitung holds 1,000,000 shares after the transaction.

• · CFO & SVP Liu Chitung acquired 1,000,000 Common Shares
• · CFO & SVP Liu Chitung disposed of 1,000,000 Common Shares

08-09-2026

Sigma Lithium Corporation filed a Form 6-K with the SEC on September 8, 2026, attaching a press release dated September 7, 2026. The filing is a routine foreign issuer report under Rule 13a-16, signed by CEO Ana Cristina Cabral. No financial data or material changes were disclosed in the filing itself.

• · Filing type is 6-K (report of foreign private issuer).
• · Commission file number: 001-40786.
• · Registrant address: 181 Bay Street, Suite 4400, Toronto, Ontario, M5J 2T3, Canada.
• · Registrant files annual reports under Form 40-F.
• · Press release dated September 7, 2026 is attached as Exhibit 99.1.

08-09-2026

Kosmos Energy Ltd. filed an 8-K on September 8, 2026, under Item 7.01 (Regulation FD Disclosure), signed by CFO Neal D. Shah. The filing contains no substantive financial or operational data, only boilerplate language regarding a note redemption notice disclaimer and signature blocks.

• · The filing is a procedural 8-K with no financial results, operational updates, or material events disclosed.
• · The document explicitly states it does not constitute a notice of redemption with respect to the Notes.

08-09-2026

Himalaya Shipping Ltd. filed a Form 6-K with the SEC on September 8, 2026, as a foreign private issuer, attaching a press release as an exhibit. The filing was signed by CEO Lars-Christian Svensen. No financial figures or performance metrics were disclosed in the cover document.

• · Filing is a Form 6-K for the month of September 2026
• · Commission file number is 001-41676
• · Principal executive office is in Hamilton, Bermuda